[SRNE] QoQ Quarter Result on 30-Sep-2021 [#Q3]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
05-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q3]
Profit Trend
QoQ- 28.10%
YoY- -42.58%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 11,461 18,385 13,076 12,062 13,511 14,255 11,505 -0.25%
PBT -220,599 -38,946 -178,068 -119,773 -167,340 2,212 -73,068 109.31%
Tax -1,050 1,463 -33,055 386 -641 -206 36 -
NP -219,549 -40,815 -144,417 -119,803 -166,615 2,510 -71,502 111.69%
Tax Rate - - - - - 9.31% - -
Total Cost 231,010 59,200 157,493 131,865 180,126 11,745 83,007 98.22%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -1,915.62 -222.00 -1,104.44 -993.23 -1,233.18 17.61 -621.49 112.23%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.55 -0.12 -0.47 -0.40 -0.57 0.01 -0.28 57.03%
EPS Diluted -0.55 -0.12 -0.47 -0.40 -0.57 0.01 -0.28 57.03%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.